| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer
1 company
Debanjan Ray last filed a Form 4 in January 2019, as Chief Financial Officer at CTMX. From May 2017 to December 2018, the filings on record show 0 open-market purchases and 18 sales. Debanjan Ray's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 5,928 shares of CTMX. The CTMX filings lean toward selling, a net 80,048 shares.
Shares as reported in the last Form 4 for each company; the most recent is from January 2019. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 1, 2018 | CTMX Cytomx Therapeutics, Inc. | Chief Financial Officer | Sell | 2,548 | $26.69 | $68,009.94 | -35.0% | |
| Jan 2, 2018 | CTMX Cytomx Therapeutics, Inc. | Chief Financial Officer | Sell | 2,500 | $21.11 | $52,775.00 | -25.5% | |
| Dec 1, 2017 | CTMX Cytomx Therapeutics, Inc. | Chief Financial Officer | Sell | 2,500 | $20.58 | $51,450.00 | -20.3% | |
| Nov 1, 2017 | CTMX Cytomx Therapeutics, Inc. | Chief Financial Officer | Sell | 2,500 | $20.00 | $50,000.00 | -17.1% | |
| Oct 2, 2017 | CTMX Cytomx Therapeutics, Inc. | Chief Financial Officer | Sell | 2,500 | $18.10 | $45,250.00 | -14.6% | |
| Sep 1, 2017 | CTMX Cytomx Therapeutics, Inc. | Chief Financial Officer | Sell | 2,500 | $17.17 | $42,925.00 | -12.7% | |
| Aug 9, 2017 | CTMX Cytomx Therapeutics, Inc. | Chief Financial Officer | Sell | 2,500 | $15.00 | $37,500.00 | -11.3% | |
| Jul 3, 2017 | CTMX Cytomx Therapeutics, Inc. | Chief Financial Officer | Sell | 2,500 | $15.47 | $38,675.00 | -10.2% |